Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

PPAR-gamma Signaling in Metabolic Homeostasis

The Indonesian Biomedical Journal · Vol. 8 No. 3 (2016) · hlm. 147–147

DOI
10.18585/inabj.v8i3.209
ISSN
2085-3297, 2355-9179
Terbit
2016-12-01
Penerbit
Secretariat of The Indonesian Biomedical Journal
Bahasa
en
Lisensi
creativecommons.org/licenses/by-nc/4.0/

Abstrak

BACKGROUND: Peroxisome proliferator-activated receptor (PPAR)-γ, or also known as nuclear receptor subfamily 1 group C member 3 (NR1C3), is a PPAR which serves as master regulator of adipocytes differentiation, and plays an important role in lipid metabolism or adipogenesis. Recent study showed that PPAR-γ is expressed in most tissue and also has critical impact in many metabolic homeostasis disorders.CONTENT: Dysregulation of PPAR-γ is correlated to the development of obesity, type 2 diabetes, atherosclerosis, cardiovascular disease, acute kidney injury, autoimmune disease, gastrointestinal disease and Alzheimer’s disease. Abundant number of new emerging compounds, with in vitro and in vivo effectiveness as natural and synthetic agonists of PPARs, are investigated, developed and used as the treatment of metabolic disorders of glucose and/or lipid and other diseases.SUMMARY: Based on all studies explanation, targeting PPAR-γ is proven to be a good therapeutic method for reducing negative effect of several metabolic homeostasis disorder. Now, many natural and synthetic agonists of PPARs are used as the treatment of metabolic disorders of glucose and/or lipid or another metabolic homeostasis disorder. Such agonists have different properties and specificities for individual PPARs receptors, different absorption and distribution, and distinctive gene expression profiles, which ultimately lead to different clinical outcomes.KEYWORDS: PPAR-γ, dysregulation, agonist, adipogenesis, metabolic disorder, homeostasis

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 133 tautan kepenulisan bersama · 52 lintas organisasi · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Padjadjaran University
  • Universitas Trisakti
  • Universitas Airlangga
  • Hasanuddin University
  • Universiti Brunei Darussalam
  • Syarif Hidayatullah State Islamic University Jakarta
  • Kyushu University
  • Organisasi lain
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Andi WijayaHasanuddin University47
Anna MeilianaPadjadjaran University46
Ferry SandraUniversitas Trisakti5
Irma Ruslina DefiPadjadjaran University2
Miswar FattahAfiliasi tidak diketahui2
Indriyanti Rafi SukmawatiHasanuddin University2
Melisa Intan BarlianaPadjadjaran University2
Anna MeilanaPadjadjaran University1
Aziiz Mardanarian RosdiantoPadjadjaran University1
Adziqa Ammara QiantoriPadjadjaran University1
Solachuddin Jauhari Arief IchwanUniversiti Brunei Darussalam1
Maria CelinnaAfiliasi tidak diketahui1
Andri SutantoUniversitas Trisakti1
Widya WulandariUniversitas Trisakti1
Reynaldo LambertusUniversitas Trisakti1
Melanie Sadono DjamilUniversitas Trisakti1
Laifa Annisa HendarminSyarif Hidayatullah State Islamic University Jakarta1
Dewi RanggainiUniversitas Trisakti1
Mas Rizky A. A. SyamsunarnoPadjadjaran University1
Keri LestariPadjadjaran University1
Dewi MuliatyAfiliasi tidak diketahui1
Muhammad Ihsan RizalUniversitas Trisakti1
Toshio KukitaKyushu University1
Ajeng DiantiniPadjadjaran University1
Andi WijayaAfiliasi tidak diketahui1
Lobredia ZarasadeUniversitas Airlangga1
Lynda HarianiUniversitas Airlangga1
Anindya ParamitaUniversitas Airlangga1
Noer Halimatus SyakdiyahUniversitas Airlangga1
Irma Melyani PuspitasariPadjadjaran University1
Eli HalimahPadjadjaran University1
Cynthia Retna SartikaPT Prodia StemCell Indonesia (Indonesia)1
Rini HendrianiPadjadjaran University1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S2764892910, pertama di-harvest 19 Nov 2026, terakhir terlihat 19 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">PPAR-gamma Signaling in Metabolic Homeostasis</dc:title><dc:creator>Rina Triana</dc:creator><dc:creator>Nurrani Mustika Dewi</dc:creator><dc:creator>Siska Darmayanti</dc:creator><dc:creator>Eka Herawati</dc:creator><dc:creator>Maria Novalentina</dc:creator><dc:creator>Made Putra Semadhi</dc:creator><dc:creator>Miftakh Nur Rahman</dc:creator><dc:subject>PPARγ</dc:subject><dc:subject>metabolic homeostasis</dc:subject><dc:subject>adipogenesis</dc:subject><dc:subject>lipid metabolism</dc:subject><dc:subject>PPAR agonists</dc:subject><dc:subject>obesity</dc:subject><dc:subject>type 2 diabetes</dc:subject><dc:subject>atherosclerosis</dc:subject><dc:subject>cardiovascular disease</dc:subject><dc:subject>acute kidney injury</dc:subject><dc:subject>Alzheimer's disease</dc:subject><dc:subject>autoimmune disease</dc:subject><dc:subject>glucose metabolism</dc:subject><dc:subject>metabolic disorders</dc:subject><dc:description xml:lang="en">BACKGROUND: Peroxisome proliferator-activated receptor (PPAR)-γ, or also known as nuclear receptor subfamily 1 group C member 3 (NR1C3), is a PPAR which serves as master regulator of adipocytes differentiation, and plays an important role in lipid metabolism or adipogenesis. Recent study showed that PPAR-γ is expressed in most tissue and also has critical impact in many metabolic homeostasis disorders.CONTENT: Dysregulation of PPAR-γ is correlated to the development of obesity, type 2 diabetes, atherosclerosis, cardiovascular disease, acute kidney injury, autoimmune disease, gastrointestinal disease and Alzheimer’s disease. Abundant number of new emerging compounds, with in vitro and in vivo effectiveness as natural and synthetic agonists of PPARs, are investigated, developed and used as the treatment of metabolic disorders of glucose and/or lipid and other diseases.SUMMARY: Based on all studies explanation, targeting PPAR-γ is proven to be a good therapeutic method for reducing negative effect of several metabolic homeostasis disorder. Now, many natural and synthetic agonists of PPARs are used as the treatment of metabolic disorders of glucose and/or lipid or another metabolic homeostasis disorder. Such agonists have different properties and specificities for individual PPARs receptors, different absorption and distribution, and distinctive gene expression profiles, which ultimately lead to different clinical outcomes.KEYWORDS: PPAR-γ, dysregulation, agonist, adipogenesis, metabolic disorder, homeostasis</dc:description><dc:publisher>Secretariat of The Indonesian Biomedical Journal</dc:publisher><dc:date>2016-12-01</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:format>application/pdf</dc:format><dc:identifier>https://doi.org/10.18585/inabj.v8i3.209</dc:identifier><dc:identifier>10.18585/inabj.v8i3.209</dc:identifier><dc:source>The Indonesian Biomedical Journal; Vol 8 No 3 (2016); 147-147</dc:source><dc:source>2085-3297</dc:source><dc:source>2355-9179</dc:source><dc:language>en</dc:language><dc:relation>https://inabj.org/index.php/ibj/article/download/209/343</dc:relation><dc:rights>https://creativecommons.org/licenses/by-nc/4.0/</dc:rights></oai_dc:dc>